JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
JW (Cayman) Therapeutics Co. Ltd. successfully conducted its Annual General Meeting on June 18, 2024, where all resolutions, including the adoption of financial statements and re-election of directors, were overwhelmingly passed by shareholders. Notably, the re-appointment of PricewaterhouseCoopers as the company auditor and the authorization for the board to issue additional shares up to 20% of the total issued shares received near-unanimous support.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.
